These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35291964)

  • 21. Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication.
    Moncrieff J; Azam K; Johnson S; Marston L; Morant N; Darton K; Wood N
    BMC Psychiatry; 2016 Jul; 16():205. PubMed ID: 27377549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physicians' reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability.
    de Kuijper GM; Hoekstra PJ
    J Intellect Disabil Res; 2017 Oct; 61(10):899-908. PubMed ID: 28560761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonadherence to antipsychotics: the role of positive attitudes towards positive symptoms.
    Moritz S; Hünsche A; Lincoln TM
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1745-52. PubMed ID: 25444234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relapse rate and predictors of relapse in patients with first-episode psychosis following discontinuation of antipsychotic medication.
    Di Capite S; Upthegrove R; Mallikarjun P
    Early Interv Psychiatry; 2018 Oct; 12(5):893-899. PubMed ID: 27734591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A qualitative exploration of family members' perspectives on reducing and discontinuing antipsychotic medication.
    Lewins A; Morant N; Akther-Robertson J; Crellin NE; Stansfeld JL; Smith R; Moncrieff J
    J Ment Health; 2024 Jun; 33(3):333-340. PubMed ID: 35521675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The least worst option: user experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample.
    Morant N; Azam K; Johnson S; Moncrieff J
    J Ment Health; 2018 Aug; 27(4):322-328. PubMed ID: 28857636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis.
    Moritz S; Favrod J; Andreou C; Morrison AP; Bohn F; Veckenstedt R; Tonn P; Karow A
    Schizophr Bull; 2013 Jul; 39(4):917-22. PubMed ID: 22337789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protocol of guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis based on pragmatic design.
    Liu CC; Hsieh MH; Chien YL; Liu CM; Lin YT; Hwang TJ; Hwu HG
    Early Interv Psychiatry; 2022 Feb; 16(2):178-185. PubMed ID: 33751764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermittent drug techniques for schizophrenia.
    Sampson S; Mansour M; Maayan N; Soares-Weiser K; Adams CE
    Cochrane Database Syst Rev; 2013 Jul; (7):CD006196. PubMed ID: 23881657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuity of antipsychotic medication use among migrant and Finnish-born populations with a psychotic disorder: a register-based study.
    Lehti V; Taipale H; Gissler M; Tanskanen A; Elonheimo M; Tiihonen J; Suvisaari J
    Psychol Med; 2023 Feb; 53(3):833-843. PubMed ID: 34074352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risperidone (depot) for schizophrenia.
    Sampson S; Hosalli P; Furtado VA; Davis JM
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004161. PubMed ID: 27078222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis.
    Siskind DJ; Harris M; Phillipou A; Morgan VA; Waterreus A; Galletly C; Carr VJ; Harvey C; Castle D
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):325-337. PubMed ID: 27426892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders.
    Mahapatra J; Quraishi SN; David A; Sampson S; Adams CE
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001470. PubMed ID: 24915451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: a randomized controlled trial.
    Constantine RJ; Andel R; McPherson M; Tandon R
    Schizophr Res; 2015 Aug; 166(1-3):194-200. PubMed ID: 26141142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population.
    Alene M; Wiese MD; Angamo MT; Bajorek BV; Yesuf EA; Wabe NT
    BMC Clin Pharmacol; 2012 Jun; 12():10. PubMed ID: 22709356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the gut microbiome mediate antipsychotic-induced metabolic side effects in schizophrenia?
    Vasileva SS; Tucker J; Siskind D; Eyles D
    Expert Opin Drug Saf; 2022 May; 21(5):625-639. PubMed ID: 35189774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
    Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC
    Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.